$CTRV..$2.24..near-term catalyst is the HepDart Meeting in December. CMX 157 Clinical Phase 1 Data. Upcoming Data in early Dec 2015 at the HepDart Meeting. CMX157 vs Tenofovir Molecule images.investorshub.advfn.com/images/uploads/2015/11/25/dditbimage.jpg